Get started
Author

Vinayak S. Walhekar

Observed names: Vinayak Walhekar, Vinayak, Walhekar, Walhekar Vinayak
ORCID: 0000-0002-5933-4692
Observed ORCID: 0000-0002-5933-4692
OpenAlex ID: A5048201075
Advanced Computational Methodologies Used in the Discovery of New Natural Anticancer Compounds
2021 · Vivek P. Chavda, Yavuz Nuri Ertas, et al. · Frontiers in Pharmacology · 61
PDF
Topical advances in PIM kinases and their inhibitors: Medicinal chemistry perspectives
2022 · Vinayak Walhekar, Chandrakant Bagul, et al. · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 39
Machine learning facilitated structural activity relationship approach for the discovery of novel inhibitors targeting EGFR
2023 · Rekha Choudhary, Vinayak Walhekar, et al. · Journal of Biomolecular Structure and Dynamics · 15
Computational and ADMET Predictions of Novel Compounds as Dual Inhibitors of BuChE and GSK-3β to Combat Alzheimer’s Disease
2024 · Saurabh G. Londhe, Vinayak Walhekar, et al. · Pharmaceutics · 12
PDF
Reconnoitering imidazopyridazines as anticancer agents based on virtual modelling approach: quantitative structure activity relationship, molecular docking and molecular dynamics
2023 · Khandekar Mangala, Walhekar Vinayak, et al. · Journal of Biomolecular Structure and Dynamics · 9
Computational Modelling Strategies for Exploring Triazolopyridazine PIM1 Kinase Inhibitors as Anticancer Agents
2022 · Vinayak Walhekar, Chandrakant Bagul, et al. · Anti-Cancer Agents in Medicinal Chemistry · 9
Integrative exploration of 2-phenylquinolin-4(1H)-one tethered 1,2,3-triazole derivatives: A comprehensive in vitro and in silico investigation towards novel anti-tubercular agents
2025 · Raut Mehavi, Walhekar Vinayak, et al. · Tuberculosis · 6
Molecular dynamics directed neuroprotective activity of alcoholic extract of Garuga pinnata Roxb. in experimental rats
2024 · Shinge Jagannath, Walhekar Vinayak, et al. · Journal of Ayurveda and Integrative Medicine · 5
Computational Investigation of Novel Compounds as Dual Inhibitors of AChE and GSK-3β for the Treatment of Alzheimer's Disease
2024 · Saurabh G. Londhe, Mangala Shenoy, et al. · Current Topics in Medicinal Chemistry · 5
From in silico and machine learning model to validation: discovery of novel amide-functionalized imidazopyridines as PIM-1 kinase inhibitors using an integrated ligand and structure-based hopping approach
2026 · Vinayak Walhekar, Shubham Dhadil, et al. · RSC Advances · 4
PDF
Django Unleashed: A Deep Dive into the Features and Advantages of the Django Framework
2024 · Shubham Dhadil, Anshul Srivastava, et al. · Rajiv Gandhi University of Health Sciences Journal of Pharmaceutical Sciences · 4
Reconnecting new tetrahydrobenzothieno-4-pyrimidine amides as potent PIM-1 kinase inhibitors via an integrated ligand, machine learning model and structure based scaffold hopping: In vitro anti-tumor investigations
2026 · Vinayak Walhekar, Amol Muthal, et al. · Bioorganic Chemistry · 3
Computational based in-silico and molecular docking approach for screening of phyto-constituents on PPAR targets in the treatment of NAFLD
2025 · Shweta Padher, Vinayak Walhekar, et al. · Research Journal of Pharmacy and Technology · 3
Deciphering Molecular Insights into Isocitrate Lyase and their Inhibitors: A Detailed Display through Medicinal Chemistry Window
2025 · Gritika Khanojia, Vinayak Walhekar, et al. · Indian Journal of Pharmaceutical Education and Research · 2
Synergistic Warriors: Design and Synthesis of Dual-Acting Schiff-Based Threaded 1,2,3-Triazole Hybrids for Potent Antineoplastic and Anti-Mycobacterial Activities
2025 · Vinayak Walhekar, Raghavendra Kulkarni, et al. · Medicinal Chemistry · 2
Molecular Insights into Salicylate Synthase: From Medicinal Chemistry Perspective
2024 · Nitin Bire, Vinayak Walhekar, et al. · Indian Journal of Pharmaceutical Education and Research · 2
Biphenyl sulfonylurea Analogs as novel antiangiogenic agents: A repositioning and molecular modelling strategy
2026 · Dharti H. Modh, Mit Joshi, et al. · Bioorganic Chemistry · 1
2-substituted 3-oxindoles as glycogen synthase kinase 3β inhibitors: insights from ML based QSAR, molecular docking, and dynamics simulations
2025 · Samved Kulkarni, Shubham Deshpande, et al. · Proceedings of the Indian National Science Academy · 1
Inspired by molecular dynamic simulation, exploring chemical constituents of alcoholic extract of Garuga pinnata computationally as inhibitors of GluN2B-containing NMDA receptors
2025 · Jagannath Shinge, Amol Muthal, et al. · Journal of Biomolecular Structure and Dynamics · 1
In Silico Prediction, Characterization, and Pre-clinical Appraisal of the Neuroprotective Effect of the Methanolic Extract of Cassytha filiformis
2026 · Nithya R, Sonal Dubey, et al. · Current Neurovascular Research
In silico investigation of thiazole–semicarbazide hybrids as dual GSK-3β/Tau inhibitors for Alzheimer’s disease
2026 · Dileep Kumar, Vinayak Walhekar, et al. · Scientific Reports
PDF
Discovery of Novel Quinazoline Thiazole Uredio Analogs as Dual Inhibitors of GSK-3β and CK-1δ as Anti-Alzheimer’s Agents: Catching Two Fish with One Net
2026 · Dileep Kumar, Vinayak Walhekar, et al. · Current Topics in Medicinal Chemistry
Fabrication of cardiovascular drug combination as Bilayer tablets: A Strategy for 24-Hour Hypertension Management
2026 · Swati S. Gaikwad, Hina D. Mehta, et al. · International Journal of Drug Delivery Technology
PDF
Works count: 25
Citation count: 187
H-index: 6
I10-index: 4
Year
Topic
Type